Navigation Links
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans™ (buprenorphine) Transdermal System CIII at PAINWeek® 2010
Date:9/9/2010

for submitting assessments of the REMS.  This information will be available at www.butransrems.com.

About Purdue Pharma L.P.Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue Pharma is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.

Contact:

Shirley Johnson203-588-7681
'/>"/>

SOURCE Purdue Pharma L.P.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Purdue Pharma L.P. Provides Free Security Mobiles and Educational Safety Videos to Good Neighbor Pharmacy Members
2. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
3. New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting
4. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
5. Meditrina Pharmaceuticals, Inc. Announces Allowance of Patent for Treatment of Endometriosis
6. Trubion Pharmaceuticals Announces Early Termination of HSR Waiting Period
7. Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts
8. Access Pharmaceuticals to Present At Rodman & Renshaw Annual Global Investment Conference in New York City
9. Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence
10. Pharmacists May Help Patients Prevent and Detect Heart Disease
11. N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... March 6, 2015 Ultra Clean ... Intuitive Surgical, the manufacturer of da Vinci® ... Cleaning System. This approval reflects the unit,s ability ... currently in place for the sterile processing industry. ... reprocessing robotic surgical instruments for re-use. ...
(Date:3/6/2015)... 2015  The German Court of Appeal has ruled that ... regimen patent for Alimta® (pemetrexed disodium) would not be infringed ... salt form of pemetrexed in Germany ... The German Court ruled in favor of the generic ... Actavis. This decision vacated the prior decision of the Regional ...
(Date:3/6/2015)... , Alemania, 6 de marzo de 2015 /PRNewswire/ ... soluciones de gestión empresarial de imagen médica, fortalece ... el nombramiento de Randolph Sternberg como ... como director de operaciones. Logo ... Sternberg será responsable de las ventas y ...
Breaking Medicine Technology:Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 3TeraRecon fortalece su posición en EMEA 2TeraRecon fortalece su posición en EMEA 3
... New Oral, Once-Daily Direct Factor Xa Inhibitor,Shows ... and Pulmonary,Embolism Compared with Enoxaparin with Similarly ... - Late-breaking Phase III clinical trial,data presented ... Thrombosis,and Haemostasis (ISTH) Congress demonstrate that once-daily,rivaroxaban ...
... Massachusetts, July 08, 2007 /PRNewswire/ -- , ... to Urgently,Implement Hospital-Wide Strategies to Optimize VTE ... Provide Appropriate,prophylaxis to Prevent VTE , Venous ... and most of these at-risk patients are ...
Cached Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 2International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 3International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 4
(Date:3/6/2015)... Ticket Down is a reputable source for authentic Garth ... After being away from the touring business for so ... letting up on his “Garth Brooks World Tour.” The tour ... to venues around the United States. The duo recently announced ... the Moda Center in Portland, OR. The husband and wife ...
(Date:3/6/2015)... As the Muscular Dystrophy Association continues to ... has hired two new Scientific Program Officers, Amanda Haidet-Phillips, ... to Grace Pavlath, Ph.D, who joined MDA late last ... and together will lead MDA as it accelerates new ... various types of neuromuscular and motor neuron diseases. ...
(Date:3/6/2015)... 2015 US Sports Football Camps expands ... – two non-contact specialty camps and one contact football ... Performance Training, located at Bowie State University and Riverdale ... specific skills, speed and strength of football athletes. The ... with Marvin Graves, former quarterback in the Canadian Football ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Johnson & ... jury verdict on March 5, 2015 in Superior Court ... to court documents, a jury of 12 awarded Mrs. ... from being implanted with an Ethicon TVT Abbrevo plastic ... men and three women also awarded $5 million in ...
(Date:3/6/2015)... Jvion, the Atlanta-based leader in ... Clostridium Difficile (C Diff) predictive use case for ... case is the latest in a broad compliment ... chronic conditions, and individual illnesses. Using the firm’s ... flags at risk individuals to help support clinician ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... Kirby Foundation of Morristown, N.J., awarded a $750,000 grant to ... New Jersey, to support the education of 10 doctoral fellows ... fund the work of a faculty member who is committed ... said Interim Dean Lucille Joel. "It is our expectation that ...
... found that a walk of just fifteen minutes can ... people manage dependencies on nicotine and other drugs have ... research shows that the same may be true for ... regular chocolate eaters were asked to either complete a ...
... 11 Davis Vision, Inc. has named,Tom Davis executive ... Mr. Davis will be responsible for all sales and ... Vision, Inc. is one of the nation,s largest managed ... No newcomer to the vision industry, Mr. Davis has ...
... Increases 23% Compared to 2007; Gross Profit Percentage ... Increases from 45% to 50% ... Inc. (OTC Bulletin Board: INIS) announces financial results for,the third ... the three and nine-month period ended September 30, 2008,was $1,245,164 ...
... to medical and investment ... ... (OTC Bulletin Board: CPCF), today launched its new Web site, http://www.CPCMedDevices.com, ... information on the company and its investigational,product, MedClose(TM). CPC is a ...
... to clean and disinfect to minimize spread of germs, ... holiday,headquarters for family and friends, it may also be a ... MAIDS Home Services to help,battle pesky germs before, during and ... in warm, soapy water. Place antibacterial,hand sanitizer in plain view ...
Cached Medicine News:Health News:Brisk walk could help chocoholics stop snacking 2Health News:Davis Vision, Inc. Names Tom Davis Executive Vice President and Chief Marketing Officer 2Health News:Davis Vision, Inc. Names Tom Davis Executive Vice President and Chief Marketing Officer 3Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results 2Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results 3Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results 4Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results 5Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results 6Health News:CPC Launches New Web Site Highlighting Medical, Research and Technical Panel, MedClose(TM) VCS Animated Video 2Health News:CPC Launches New Web Site Highlighting Medical, Research and Technical Panel, MedClose(TM) VCS Animated Video 3
... tissue valve from Medtronic, is the only ... Mosaic valve builds upon three decades of ... choice for patients who require aortic or ... For more than 20 years, Medtronics mitral ...
... Hancock® II bioprosthesis from Medtronic ... of proven clinical experience. Worldwide ... freedom from structural valve deterioration ... mitral bioprostheses is substantially better ...
... bioprosthesis from Medtronic has more ... clinical experience. Worldwide clinical studies ... structural valve deterioration with Hancock® ... is substantially better than results ...
Attain Venogram Balloon Catheter....
Medicine Products: